|
Mar 1
|
Is Sanofi (SNY) The Best Immunology Stock To Buy Now?
|
|
Feb 28
|
Q4 2024 Cytokinetics Inc Earnings Call
|
|
Feb 28
|
Kymera Therapeutics Inc (KYMR) Q4 2024 Earnings Call Highlights: Strategic Collaborations and ...
|
|
Feb 28
|
Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
|
|
Feb 27
|
Q4 2024 Vir Biotechnology Inc Earnings Call
|
|
Feb 27
|
Novavax Q4 Loss Narrower Than Expected, Sales Beat Estimates
|
|
Feb 27
|
Novavax reports large quarterly revenue declines, rethinks its strategic direction
|
|
Feb 27
|
Novavax shares up on fourth quarter earnings beat
|
|
Feb 27
|
Novavax sees royalties, reduced expenses on COVID vaccines from Sanofi partnership
|
|
Feb 26
|
Sanofi’s Sarclisa combo approved in Japan for newly diagnosed MM
|
|
Feb 14
|
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
|
|
Feb 14
|
Banks on the Hook for Sanofi Buyout Face Agonizing Wait to Sell
|
|
Feb 13
|
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
|
|
Feb 13
|
J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results
|
|
Feb 13
|
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
|
|
Feb 13
|
Sanofi to take $250M charge on study failure for E. coli vaccine
|
|
Feb 13
|
Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
|
|
Feb 12
|
Sanofi (SNY): Among the Best International Dividend Stocks to Buy Now
|
|
Dec 31
|
Drugmakers to raise US prices on over 250 medicines starting Jan. 1
|
|
Oct 4
|
Market Chatter: Sanofi Healthcare Suitors Revise Offers Amid Talc Liability Concerns
|